More tools:Markets·Screener·Research·Chat

BiomX Inc. (PHGE) Financial Statements

BiomX Inc.
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG00MNX7SR5
XASE · usd
1.62▲ 1.47 (945.16%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value—
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt—
Trading Information
Previous Close0.16
Day's Range1.50 – 1.72
52-Week Range0.12 – 8.50
Volume524.9K
Avg Volume1.6M
Share Statistics
Shares Outstanding
Employees57
ExchangeXASE
Listed2019-03-13
Share count as of August 18, 2026
Loading Income Statement…
Key questions about BiomX Inc. (PHGE)
What is BiomX Inc.'s Market Cap?
BiomX Inc.'s Market Cap is $43.3M, based on as-reported figures from SEC (XBRL) filings.
What is BiomX Inc.'s Net Income (TTM)?
BiomX Inc.'s Net Income (TTM) is -$47.7M, based on as-reported figures from SEC (XBRL) filings.
What is BiomX Inc.'s EBITDA?
BiomX Inc.'s EBITDA is -$32.3M, based on as-reported figures from SEC (XBRL) filings.
What is BiomX Inc.'s Diluted EPS (TTM)?
BiomX Inc.'s Diluted EPS (TTM) is -1.78, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues———
Cost of revenues———
Gross profit———
% of revenue29.2%———
Operating expenses:
Research and development (“R&D”) expenses, net
General and administrative expenses
Operating loss
% of revenue1630.7%———
Other expenses (income)
Net gain from deconsolidation of subsidiary——
Loss (income) from change in derivatives financial instruments measured at fair value——
Interest expenses
Interest expense - related parties———
Day one loss upon entering transaction——
Finance expense, net——
Net loss before tax
Net loss——
% of revenue1158.4%———
Net loss attributable to non-controlling interests———
Net loss attributable to the Company’s stockholders———
Basic loss per share of Common Stock (in Dollars per share)—
Diluted loss per share of Common Stock (in Dollars per share)—